Trial Profile

A double-blind, randomized study assessing efficacy of 20% oxybutynin hydrochloride lotion (20% OL) in reducing palmar sweat volume in patients with primary palmar hyperhidrosis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 23 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Nov 2023 Results of an open-label extension study evaluating the safety and efficacy of a novel 20% oxybutynin hydrochloride lotion for primary palmar hyperhidrosis published in the Journal of Dermatology.
05 Apr 2023 New trial record
27 Mar 2023 Primary endpoint Response was defined as a reduction of sweat volume of at least 50% from baseline has been met according results published in the Journal of the American Academy of Dermatology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com